Benegut (Perilla frutescens)

Benegut is a standardized extract of Perilla frutescens leaf containing rosmarinic acid and luteolin as primary bioactives, which modulate gut barrier integrity and intestinal smooth muscle function. It is clinically studied for reducing functional gastrointestinal symptoms including bloating, gas, and abdominal discomfort.

Origin & History

Benegut is a proprietary extract derived from the leaves of Perilla frutescens (L.) Britton, an aromatic annual herb in the Lamiaceae family native to East Asia. Developed specifically for gastrointestinal relief, this branded ingredient is produced through extraction methods that concentrate prokinetic, antispasmodic, and anti-inflammatory compounds, particularly rosmarinic acid and luteolin.

Historical & Cultural Context

Perilla frutescens, known as 'zi su' in Traditional Chinese Medicine, has been used for over 2,000 years in TCM and Japanese Kampo medicine for allergic diseases, asthma, and digestive issues. The plant was first officially recognized as a medicinal food by China's Ministry of Health and appears in traditional formulas like Saiboku-to for respiratory and gastrointestinal conditions.

Health Benefits

• Significantly reduces bloating and gas (p=0.0003 for bloating improvement in 4-week RCT) - Moderate evidence
• Improves knee osteoarthritis pain by 65% more than placebo (19.6±10.9 vs. 6.8±10.5 VAS reduction, p<0.001) - Moderate evidence
• Enhances gastrointestinal comfort and reduces rumbling in healthy adults - Preliminary evidence
• Shows strong effects on allergic rhinoconjunctivitis, particularly in youth - Traditional/observational evidence
• May provide hypolipidemic benefits and cognitive support through antioxidant activity - Preliminary evidence

How It Works

Benegut's primary bioactive, rosmarinic acid, inhibits prostaglandin E2 synthesis by suppressing COX-2 enzyme activity and downregulates NF-κB signaling, reducing intestinal inflammation and visceral hypersensitivity. Luteolin further stabilizes mast cells in the gut mucosa, limiting histamine release that contributes to bloating and cramping. These compounds collectively support tight junction protein expression (including claudin-1 and occludin), reinforcing intestinal barrier integrity and reducing paracellular permeability that drives gas accumulation and discomfort.

Scientific Research

Key clinical evidence includes a double-blind RCT (n=50, NCT01931930) showing significant improvements in bloating and gas passage over 4 weeks, though high placebo effects were noted. A larger osteoarthritis RCT (n=80, PMID: 36998613) demonstrated superior pain reduction with 700mg twice daily for 8 weeks, with 75 participants completing the study. A systematic review of interventional studies highlighted effects on allergic conditions and GI function, but noted limited RCTs available.

Clinical Summary

A 4-week randomized controlled trial demonstrated that Benegut significantly reduced bloating versus placebo (p=0.0003), establishing moderate-quality evidence for its primary indication. A separate RCT found a 65% greater reduction in knee osteoarthritis pain scores compared to placebo (VAS reduction: 19.6±10.9 vs. 6.8±10.5, p<0.001), suggesting systemic anti-inflammatory activity beyond gut-specific effects. Studies have also documented improvements in intestinal rumbling and overall gastrointestinal comfort, though sample sizes in published trials are generally modest (typically under 100 participants). Overall evidence is classified as moderate; larger, independently replicated trials are needed to elevate confidence levels.

Nutritional Profile

Benegut is a standardized extract of Perilla frutescens (shiso) leaf, concentrated for specific bioactive compounds rather than consumed as a whole food. Key bioactive constituents include: Rosmarinic acid (primary polyphenol, typically 15-30% of standardized extract by weight) — a hydroxycinnamic acid derivative with demonstrated anti-inflammatory and mast cell-stabilizing activity; Luteolin and apigenin (flavonoids, present at ~1-5% in standardized extracts) — contribute to antihistamine and anti-inflammatory effects; Perillaldehyde and limonene (monoterpenes in essential oil fraction, ~40-55% of volatile compounds) — responsible in part for GI motility modulation; Tormentic acid and oleanolic acid (triterpenoids) — present in smaller quantities, contribute to anti-inflammatory pathways. The extract is typically delivered at 150 mg/day clinical dose. As a concentrated extract rather than whole leaf: macronutrient contribution is negligible at functional doses (calories <5 kcal per serving). Whole Perilla leaf for reference contains ~3-4g protein/100g dry weight, ~6-7g dietary fiber/100g dry weight, and notable micronutrients including calcium (~230 mg/100g), iron (~7.5 mg/100g), vitamin C (~26 mg/100g), and beta-carotene (~860 mcg/100g). Bioavailability: Rosmarinic acid is well-absorbed in the small intestine with peak plasma levels ~30 minutes post-ingestion; colonic microbiota further metabolize it into caffeic acid and hydrocaffeic acid derivatives, extending bioactive exposure.

Preparation & Dosage

Clinically studied doses include 700mg twice daily (1400mg/day) for 8 weeks in osteoarthritis studies using leaf extract. For gastrointestinal discomfort, proprietary Benegut extract was used over 4 weeks, though specific dosage was not detailed in the pilot study. Traditional decoctions used 500mg/kg in animal models. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Probiotics, Ginger extract, Peppermint oil, Digestive enzymes, Slippery elm

Safety & Interactions

Benegut is generally well-tolerated in clinical trials, with no serious adverse events reported at studied doses, and its side effect profile is comparable to placebo in published RCTs. Due to rosmarinic acid's mild COX-2 inhibitory activity, caution is warranted when combining with NSAIDs or anticoagulants such as warfarin, as additive antiplatelet effects are theoretically possible. Perilla frutescens contains small amounts of perillaldehyde, which may cause contact sensitization in rare individuals, and those with Lamiaceae family plant allergies should consult a physician before use. Insufficient safety data exist for use during pregnancy or lactation, so use is not recommended in these populations without medical supervision.